Combining a support crossing catheter with intravascular ultrasound imaging, the Provisio SLT IVUS System offers simultaneous real-time visualization and measurement of vessel lumen.
The Food and Drug Administration (FDA) has granted 510(k) clearance for the Provisio SLT IVUS System, which features a support crossing catheter that integrates intravascular ultrasound, enabling clinicians to assess blood vessel lumen and obtain vessel measurements at the same time through Sonic Lumen Tomography (SLT).
Provisio Medical , the manufacturer of the Proviso SLT IVUS System, said the Provisio SLT IVUS System’s inclusion of the SLT IVUS Support Crossing Catheter provides dual functionality in interventional procedures with an ultrasound transducer array at the distal end of the catheter.
Through the use of Sonic Lumen Tomography (SLT), the newly FDA-cleared Provisio SLT IVUS System provides clinicians with simultaneous real-time visualization and measurement of vessel lumen during interventional procedures for patients with peripheral vascular disease. (Image courtesy of Provisio Medical.)
Incorporating intravascular ultrasound capability into a front-line support crossing catheter may help simplify workflows, reduce iodinated contrast media (ICM) and reduce radiation exposure for patients being treated for peripheral vascular disease (PVD), according to Provisio Medical.
"Clinical outcomes in peripheral vascular disease have consistently been shown to benefit from accurate intravascular measurements, yet adoption has been limited by the additional procedure time and training required to interpret images" noted S. Eric Ryan, M.D., the chief executive officer of Provisio Medical. "Thanks to the ease-of-use of SLT IVUS, which can be incorporated more efficiently in the peripheral vascular workflow, we believe there is the possibility of increased adoption and therefore improved outcomes for many more patients with potentially devastating peripheral vascular disease."
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.